ANRim Biotech was founded in 2023 by a multidisciplinary team to develop new nanotechnologies for healthcare, which is believed had enormous potential. With the rapid expansion of ANRim, we are proud our entrepreneurial spirit and look forward to being a part of this exciting field for years to come.

Today, ANRim’s innovations are protected by more than 20 patents, we engage in and fund research projects with our university collaborators and industry partners, and we are committed to develop the next generation of engineered cell therapies and transcriptomic technologies.